Imagine this scenario: After receiving government research funding for many years, a small biotech company achieves the near impossible — approval from regulators of a safe and effective drug that reverses the effects of Alzheimer’s disease...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129